Barry P Clark

This inventor holds 23 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Eli Lilly and Company, Lilly Industries, Inc.. Active years: 1981-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barry P Clark. Retrieved from https://idiyas.com/inventor/barry-p-clark

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23

% Patents Active = 60.9

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 78(Granted Patents)

Location History:

Fleet, GB (1981 - 1984)
Froyle, GB (1995)
Hampshire, GB (2002)
Basingstoke, GB (2007 - 2012)
Lower Froyle, GB (1990 - 2013)

Company Filing History:

13 out of 4,522

Eli Lilly and Company

patents

10 out of 158

Lilly Industries, Inc.

patents

Years Active: 1981-2013

Loading Chart...

Areas of Expertise:

MGlu 2/3 Agonists

Monoamine Uptake Inhibitors

CNS Active Agents

Norepinephrine Reuptake Inhibitors

Pyridinylmorpholine Derivatives

Pharmaceutical Compounds

Dopaminergic Agents

Xanthene Compounds

Thieno[2,3-O]azepine Compounds

Aminomethyl-Azacycle Derivatives

Phenylglycine Derivatives

Macrocyclic Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8575214 - MGlu 2/3 agonists (2013-11-05),

2. 8202873 - 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists (2012-06-19),

3. 7619096 - 3-Aminopyrrolidines as inhibitors of monoamine uptake (2009-11-17),

4. 7615648 - Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake (2009-11-10),

5. 7521462 - 4-Amino-piperidine derivatives as monoamine uptake inhibitors (2009-04-21),

6. 7488728 - Pyridinylmorpholine derivatives (2009-02-10),

7. 7432280 - 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake (2008-10-07),

8. 7384941 - 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors (2008-06-10),

9. 7294623 - Benzyl morpholine derivatives (2007-11-13),

10. 6482824 - Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists (2002-11-19),

11. 6054448 - 2-amino-2-(3-substituted cyclobutyl) acetic acid derivatives (2000-04-25),

12. 5891899 - Pharmaceutical xanthene compounds (1999-04-06),

13. 5863947 - Phenylglycine derivatives useful for treating disorders of the central (1999-01-26),

14. 5580900 - Macrocyclic compounds (1996-12-03),

15. 5574158 - Compounds (1996-11-12),

Title: Barry P Clark - Inventor from Lower Froyle, GB

Introduction: Barry P Clark is a renowned inventor hailing from Lower Froyle, GB, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Barry P Clark holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical equipment.

Career Highlights: Throughout his illustrious career, Barry P Clark has been recognized for his innovative solutions that have significantly impacted industries such as healthcare, telecommunications, and environmental sustainability.

Collaborations: Barry P Clark has collaborated with leading research institutions, universities, and multinational companies to further develop and implement his inventions on a global scale, showcasing his versatility and expertise in the field of technology.

Conclusion: Barry P Clark's dedication to pushing the boundaries of innovation and his passion for creating solutions to real-world problems have solidified his reputation as a pioneering inventor in the technological landscape.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]